| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT06807281 | A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older… | Atopic Dermatitis | Recruiting |
| NCT06807268 | A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age… | Eczema | Recruiting |
| Phase 2 | |||
| NCT07242638 | Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With… | Atopic Dermatitis | Recruiting |
| NCT06597396 | Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe… | Post-COVID Condition | Active, Not Recruiting |
| NCT05743244 | Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1… | Diabetes Mellitus, Type 1 | Active, Not Recruiting |
| Not specified | |||
| NCT06899204 | Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic… | Atopic Dermatitis | Recruiting |
| NCT05387980 | A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis. | Atopic Dermatitis | Active, Not Recruiting |
| NCT07448363 | Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica | Atopic Dermatitis | Not Yet Recruiting |